Results 201 to 210 of about 295,535 (265)

Editorial: Reporting baseline variables - descriptive summaries rather than inferential comparisons: editorial series on improving reporting and methodological rigor in scientific articles. [PDF]

Acta Orthop
Christensen R, Reito A, Haugegaard T, Overgaard S.   +3 more
europepmc   +1 more source

Streamlining Diagnosis of Bardet–Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Considerable advances have been made in our understanding of Bardet–Biedl syndrome (BBS), particularly in its core clinical features and molecular genetics, warranting an update to the existing diagnostic criteria framework. Using a rigorous, evidence‐based, and consensus‐driven process, a multidisciplinary group of international experts and ...
Jeremy J. Pomeroy, Jesse Richards, Brooke R. Sweeney, Seema Kumar, Katie E. Queen, Joshua Zaritsky, Carl H. Cramer, Elias I. Traboulsi, Brittni A. Scruggs, Erica E. Davis, Ekaterina Keifer, Emma McGibbon, Timothy Ogden, Bendert De Graaf, Tonia Hymers, Elizabeth Forsythe, Philip Beales   +16 more
wiley   +1 more source

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit. [PDF]

Cochrane Database Syst Rev
Vieira AGS, Pinto ACPN, Garcia AAA, Nawa RK, Mól CG, Duenas JD, Atallah ÁN, Shrestha GS, Schultz MJ, Saconato H, Trevisani VF.   +10 more
europepmc   +1 more source

Editorial: Promoting replicability: empowering method and applied researchers in driving reliable results. [PDF]

Front Psychol
Fernández-García MP, Vallejo-Seco G, Livácic-Rojas P.   +2 more
europepmc   +1 more source

Editorial: AntibodyPlus therapeutics in oncology: innovative mechanisms, therapeutic strategies, and clinical advances. [PDF]

Front Oncol
Chen Y, Ren P, Chen H, He M.
europepmc   +1 more source

Editorial: Bioresorbable materials: What is new? [PDF]

Front Bioeng Biotechnol
Filipović N, Stevanović MM, Liu S, Zheng K.   +3 more
europepmc   +1 more source

Editorial: Pharmacology Education Special Issue. [PDF]

Pharmacol Res Perspect
Koenig JA, Tucker SJ.
europepmc   +1 more source

A Multicenter, Open‐Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST)

American Journal of Hematology, EarlyView.
Kenneth I. Ataga, Pablo Bartolucci, Santosh L. Saraf, Vimal K. Derebail, Adlette Inati, Jeffrey D. Lebensburger, Laurie DeBonnett, Rodolfo D. Cancado, Claire C. Sharpe   +8 more
wiley   +1 more source

Editorial: Applications and advances of carbon-based materials in electrochemistry. [PDF]

Front Chem
Cui M, Li P, Liu Y, Wang S.
europepmc   +1 more source